Atlas Trials

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

Clinical trial NCT00406757 · COMPLETED

Trial details

NCT number
NCT00406757
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic
Start date
2006-08-30
Primary completion
2009-07-15
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.